ACVC Partners — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
RxList is an online medical resource providing detailed pharmaceutical information on brand and generic drugs, written and reviewed by pharmacists and physicians.
Digital HealthHealthtechMedia & EntertainmentSan Clemente, US
Co-investorsHealthCapAlleyCorpAnzu PartnersConstellation Technology VenturesIn-Q-TelMaverick Silicon+5 more
Datumo Eval is an LLM evaluation platform that generates industry-specific question datasets from source documents and assesses LLM models and LLM-powered services using default or custom metrics via an agentic flow of multiple LLM agents.
AI & Machine LearningCybersecurityData & InfrastructureDeveloper Tools
Michael Hwang(Founder)inMichael (Minyoung) Hwang(Founder)inHawk Shin(Co-Founder)David Kim(Chief Executive Officer (CEO))David J. Kim(Founder)
Co-investorsSalesforce VenturesKB InvestmentKiwoom InvestmentSBI InvestmentShinhan Venture Investment
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.







